Document is current
Any future updates will be listed below
-
Authors
HOERTEL, Nicolas https://orcid.org/0000-0002-7890-1349
MÜHLE, Christiane https://orcid.org/0000-0001-7517-9154
MÜLLER, Christian P. https://orcid.org/0000-0002-5325-9900
CHAIEB, Hédi
SCHEER, Valentin
FAYAD, Mahdi
SÁNCHEZ-RICO, Marina
LIMOSIN, Frédéric https://orcid.org/0000-0002-0976-1514
KORNHUBER, Johannes https://orcid.org/0000-0002-8096-3987
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (KO 947/20-1)
- License Information
-
More Information
Article History
Received: 21 November 2025
Revised: 11 April 2026
Accepted: 30 April 2026
First Online: 13 May 2026
Competing interests
: N.H. is co-founder and scientific director of CERAMED, a company developing sphingolipid-based diagnostics and therapeutics under the French PACTE law public-private partnership. C.M. and J.K. are unpaid scientific advisors of CERAMED through an academic agreement with Universität Erlangen-Nürnberg. H.C. and M.S.R. are scientific consultants to CERAMED. This work received no funding from CERAMED or other industry sources. The remaining authors declare no competing interests.
